期刊文献+

血浆脑钠肽浓度对心力衰竭患者评价预后的临床观察 被引量:11

Clinical Study of the Relationship between Blood B-type Natriuretic Peptide Level and Heart Dysfunction
下载PDF
导出
摘要 目的观察血浆脑钠肽浓度和心脏超声,心胸比随心功能改善的数值关系,探讨血浆BNP浓度对心衰病人预后判断的意义。方法比较165例心功能不全患者治疗前、治疗后1个月及3个月的左室射血分数(LVEF)、心胸比值及BNP浓度。结果血浆BNP水平低的患者预后好,反之预后差;并BNP水平在1个月就有变化,在3个月LVEF及心胸比才有变化。结论BNP水平与心力衰竭患者的预后有关;并且这种变化早于心脏功能指标LVEF及心胸比的变化。 Objective To evaluate the value of BNP in prognosis of patients with heart failure by studying the correlation between blood BNP level and severity of heart dysfunction which was assessed by functional classification,and cardiothoracic ratio (CTR). Methods 165 patients accepted treatment according to guidline for heart failure. Blood BNP,LVEF and CTR were measured before treat,one month after treat and three months after treat,to evaluate the value of BNP level in short-term prognosis in patients of heart failure. Results When the BNP level was more lower, prognosis of the patients would be better. During three-month follow-up peried,BNP levels,LVEF and CTR were observed, blood BNP concentration decreased in one month and much more in three months(P〈 0.05). Conclusion The change of blood BNP level after treatment can reflect treatment-responsiveness in heart failure patients,increase of BNP level suggested poor prognosis. Patients with BNP level decreased greatly had good prognosis than those with BNP level decreased slightly. BNP can be a predictor for short-term prognosis.
作者 刘敏
出处 《中国现代医生》 2009年第2期65-66,共2页 China Modern Doctor
关键词 脑钠肽 心功能不全 心脏超声学检查 心胸比 B-type natriuretic peptide Heart dysfunction Cardiothoracic ratio
  • 相关文献

参考文献4

二级参考文献57

  • 1[1]Cowie MR,Struthers DA.Value of natriuretic peptides in assessmcnt of patients with possible new heart failure in primary care[J].Lancet,1997,350:1349-1353.
  • 2[2]MaiselA.B-type natriuretic peptide levels:diagnostic and therapentic potential[J].Cardiovase Toxieol,2001,1:159-164.
  • 3Sudon T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature,1988,322:78-81.
  • 4Venugopal J. Cardiac natriuretic peptide-hope or hype? J Clinical Pharmacy Theraperutics, 2001,26:15-31.
  • 5Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormaones in humans. Horm Metab Res,1999,31:487-498.
  • 6Mair J, Friedl W, Thomas S, et al. Natriuretic peptides in assessment of left-ventricular dysfunction.Scand J Clin Invest, 1999,(Supple 230):132-142.
  • 7Sagnella GA. Mearement and significance of circulating natriuretic peptides in cardiovascular disease. Clinical Science,1998,95:519-529.
  • 8Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand,2001,171:395-403.
  • 9Goto T, Takase H, Toriyama T, et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart, 2003,89:1303-1307.
  • 10Smith H, Picking R M,Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ, 2000, 320:1.

共引文献86

同被引文献102

引证文献11

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部